Combray dropper containing Oxofulleram and Grape Seed Oil.
Image Source: Solenne.
Oxofulleram (Docosyloxymethoxybenzyl Azafullerenedione) is a lipophilic (oil-soluble) C60 fullerene-derived ketolactam unique to Combray, developed by Solenne of The Netherlands.
Oxofulleram has been shown to be highly effective at reducing the appearance of free radical damage such as that associated with age, sun, and inflammation.
Oxofulleram is derived from a pure form of carbon called fullerene.
Forms of fullerene are being investigated as antioxidants in the treatment and prevention of Parkinson's, Alzheimer's, Multiple Sclerosis and aging.
Oxofulleram is especially notable for not becoming a free radical in the process of acting as an antioxidant — it is free of pro-oxidant effects seen in antioxidants such as Vitamins E and C.
Oxofulleram is also stable — unlike the majority of Vitamin C serums and some other antioxidants, it does not degrade by oxidation before reaching the end-user.
Oxofulleram is a gentle yet potent anti-inflammatory, making it suitable for all skin types and conditions, including rosacea and psoriasis.